Article Details

Bioline RX (NASDAQ:BLRX) Upgraded by Zacks Investment Research to Hold

Retrieved on: 2018-02-16 09:18:45

Tags for this article:

Click the tags to see associated articles and topics

Bioline RX (NASDAQ:BLRX) Upgraded by Zacks Investment Research to Hold. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC lifted its stake in shares of Bioline RX Ltd (NASDAQ:BLRX) by 60.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 434,700 shares of the biotechnology company's stock after purchasing an additional ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up